Immunoglobulin abnormalities and current status of treatment of multiple myeloma.
D000477:Alkylating Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis*; D000937:Antigen-Antibody Reactions; D001796:Blood Protein Disorders / Q000276:immunology*; D004140:Dinitrophenols; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D006801:Humans; D008259:Macroglobulins / Q000032:analysis; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D013057:Spectrum Analysis; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology; D005719:gamma-Globulins / Q000032:analysis*
D000477:Alkylating Agents; D000728:Androgens; D000906:Antibodies; D004140:Dinitrophenols; D008259:Macroglobulins; D005719:gamma-Globulins; D005459:Fluorides